Terns Pharmaceuticals, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -4,973.30%
EBIT Margin -4,986.00%
EBITDA Margin -4,986.00%
Operating Margin -4,986.00%
Net Margin -5,015.80%
FCF Margin -4,216.70%
Efficiency
Assets Average 130.18M227.55M
Equity Average 21.43M218.62M
Invested Capital -104.56M160.30M276.94M
Asset Utilization Ratio 0.01
Leverage & Solvency
Debt to Equity -0.11
Debt Ratio 0.14
Equity Ratio -1.270.950.96
Valuation
Enterprise Value 477.65M12.66M99.79M401.05M470.56M
Market Capitalization 552.50M178.64M382.91M401.05M470.56M
Return Ratios
Return on Sales -50.24%
Return on Capital Employed -0.40%-0.28%
Return on Assets -0.39%-0.27%
Return on Equity -2.34%-0.28%